Cargando…
Hospital Resources Used for Ectopic Pregnancy Treatment by Laparoscopy and Methotrexate
OBJECTIVE: To compare resources used in the medical and laparoscopic treatment of unruptured ectopic pregnancy. METHODS: We prospectively recorded all the medical resources required in the treatment of unruptured ectopic pregnancy. The study period ranged from January 1, 1995 to June 30, 1998. Singl...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Society of Laparoendoscopic Surgeons
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3015437/ https://www.ncbi.nlm.nih.gov/pubmed/11394423 |
_version_ | 1782195513736560640 |
---|---|
author | Lecuru, Fabrice Camatte, Sophie Viens-Bitker, Catherine Chasset, Sophie Leonard, Franck Taurelle, Roland |
author_facet | Lecuru, Fabrice Camatte, Sophie Viens-Bitker, Catherine Chasset, Sophie Leonard, Franck Taurelle, Roland |
author_sort | Lecuru, Fabrice |
collection | PubMed |
description | OBJECTIVE: To compare resources used in the medical and laparoscopic treatment of unruptured ectopic pregnancy. METHODS: We prospectively recorded all the medical resources required in the treatment of unruptured ectopic pregnancy. The study period ranged from January 1, 1995 to June 30, 1998. Single-dose intramuscular methotrexate injections were administered in 55 women (group I). This therapeutic option was provided on an outpatient basis in small EP (β-HCG level < 5000 IU/L and hematosalpinx diameter < 3 cm). Serial clinical controls and biologic tests were performed until bHCG became negative. Forty women underwent a laparoscopic salpingostomy because they refused the methotrexate regimen or had “social” contra-indications (ie, predictable difficulties in the follow-up) (group II). Twenty-one patients underwent conservative laparoscopic treatment because of “medical” contraindications to methotrexate (group III). We recorded the resources used with the outpatient and inpatient treatment in each group (methotrexate consumption, operating room acts, length of hospital stay, clinical examinations, biological tests, and sonograms during the follow-up). RESULTS: We observed similar cure rates in each group, but it took significantly longer for β-HCG to become negative in group 1. However, hospitalization was significantly less often required, and the length of hospital stay was shorter in this group. But length of follow-up, number of office visits, biological tests, sonograms, and subsequent readmissions were significantly more frequent after methotrexate. Despite more severe clinical presentations for patients in group III, we didn't find any significant differences in the hospital resources used in this group in comparison with those used in group II. CONCLUSIONS: The outpatient methotrexate option may result in low consumption of resources for a hospital because most of the follow-up can be performed by city practitioners and laboratories. For the laparoscopic option, efforts should be made to reduce the postoperative hospital stay. |
format | Text |
id | pubmed-3015437 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2001 |
publisher | Society of Laparoendoscopic Surgeons |
record_format | MEDLINE/PubMed |
spelling | pubmed-30154372011-02-17 Hospital Resources Used for Ectopic Pregnancy Treatment by Laparoscopy and Methotrexate Lecuru, Fabrice Camatte, Sophie Viens-Bitker, Catherine Chasset, Sophie Leonard, Franck Taurelle, Roland JSLS Scientific Papers OBJECTIVE: To compare resources used in the medical and laparoscopic treatment of unruptured ectopic pregnancy. METHODS: We prospectively recorded all the medical resources required in the treatment of unruptured ectopic pregnancy. The study period ranged from January 1, 1995 to June 30, 1998. Single-dose intramuscular methotrexate injections were administered in 55 women (group I). This therapeutic option was provided on an outpatient basis in small EP (β-HCG level < 5000 IU/L and hematosalpinx diameter < 3 cm). Serial clinical controls and biologic tests were performed until bHCG became negative. Forty women underwent a laparoscopic salpingostomy because they refused the methotrexate regimen or had “social” contra-indications (ie, predictable difficulties in the follow-up) (group II). Twenty-one patients underwent conservative laparoscopic treatment because of “medical” contraindications to methotrexate (group III). We recorded the resources used with the outpatient and inpatient treatment in each group (methotrexate consumption, operating room acts, length of hospital stay, clinical examinations, biological tests, and sonograms during the follow-up). RESULTS: We observed similar cure rates in each group, but it took significantly longer for β-HCG to become negative in group 1. However, hospitalization was significantly less often required, and the length of hospital stay was shorter in this group. But length of follow-up, number of office visits, biological tests, sonograms, and subsequent readmissions were significantly more frequent after methotrexate. Despite more severe clinical presentations for patients in group III, we didn't find any significant differences in the hospital resources used in this group in comparison with those used in group II. CONCLUSIONS: The outpatient methotrexate option may result in low consumption of resources for a hospital because most of the follow-up can be performed by city practitioners and laboratories. For the laparoscopic option, efforts should be made to reduce the postoperative hospital stay. Society of Laparoendoscopic Surgeons 2001 /pmc/articles/PMC3015437/ /pubmed/11394423 Text en © 2001 by JSLS, Journal of the Society of Laparoendoscopic Surgeons. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits for noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited and is not altered in any way. |
spellingShingle | Scientific Papers Lecuru, Fabrice Camatte, Sophie Viens-Bitker, Catherine Chasset, Sophie Leonard, Franck Taurelle, Roland Hospital Resources Used for Ectopic Pregnancy Treatment by Laparoscopy and Methotrexate |
title | Hospital Resources Used for Ectopic Pregnancy Treatment by Laparoscopy and Methotrexate |
title_full | Hospital Resources Used for Ectopic Pregnancy Treatment by Laparoscopy and Methotrexate |
title_fullStr | Hospital Resources Used for Ectopic Pregnancy Treatment by Laparoscopy and Methotrexate |
title_full_unstemmed | Hospital Resources Used for Ectopic Pregnancy Treatment by Laparoscopy and Methotrexate |
title_short | Hospital Resources Used for Ectopic Pregnancy Treatment by Laparoscopy and Methotrexate |
title_sort | hospital resources used for ectopic pregnancy treatment by laparoscopy and methotrexate |
topic | Scientific Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3015437/ https://www.ncbi.nlm.nih.gov/pubmed/11394423 |
work_keys_str_mv | AT lecurufabrice hospitalresourcesusedforectopicpregnancytreatmentbylaparoscopyandmethotrexate AT camattesophie hospitalresourcesusedforectopicpregnancytreatmentbylaparoscopyandmethotrexate AT viensbitkercatherine hospitalresourcesusedforectopicpregnancytreatmentbylaparoscopyandmethotrexate AT chassetsophie hospitalresourcesusedforectopicpregnancytreatmentbylaparoscopyandmethotrexate AT leonardfranck hospitalresourcesusedforectopicpregnancytreatmentbylaparoscopyandmethotrexate AT taurelleroland hospitalresourcesusedforectopicpregnancytreatmentbylaparoscopyandmethotrexate |